Elicio Therapeutics, Inc. (ELTX)

2.565 0.00 (0.00%) USD  |  NASDAQ  |  Sep 02, 16:00
2.565 0.00 (0.00%) After-Hours: 20:00
More

Elicio Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 20, 2026 --
August 18, 2026 --
August 17, 2026 --
August 14, 2026 --
July 02, 2026 --
June 25, 2026 --
June 24, 2026 --
June 22, 2026 --
June 18, 2026 --
June 15, 2026 --
June 10, 2026 --
May 28, 2026 --
May 12, 2026 --
April 29, 2026 --
April 22, 2026 --
April 15, 2026 --
March 13, 2026 --
Date Value
January 27, 2026 --
January 20, 2026 --
January 12, 2026 --
December 11, 2025 --
November 19, 2025 --
November 14, 2025 --
September 17, 2025 --
August 08, 2025 --
August 07, 2025 --
July 17, 2025 --
June 25, 2025 --
May 16, 2025 --
April 02, 2025 --
April 01, 2025 --
August 23, 2024 --
May 16, 2024 --
May 01, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Precigen, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade